Bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: A meta-analysis of individual patients’ data from 3 phase III studies-Reference-Cited by-同舟云学术

Bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: A meta-analysis of individual patients’ data from 3 phase III studies

Published:2021-06 Issue: Volume:97 Page:102202
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Salvatore Lisa^ORCID,Bria Emilio^ORCID,Sperduti Isabella,Hinke Axel^ORCID,Hegewisch-Becker Susanna,Aparicio Thomas^ORCID,Le Malicot Karine,Boige Valérie^ORCID,Koeberle Dieter,Baertschi Daniela^ORCID,Dietrich Daniel,Tortora Giampaolo,Arnold Dirk

Funder

Associazione Italiana per la Ricerca sul Cancro

Università Cattolica del Sacro Cuore

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference19 articles.

1. https://www.who.int/news-room/fact-sheets/detail/cancer.

2. Benson AB, Venook AP, Al-Hawary MM, Arain MA, Chen YJ, Ciombor KK et al. Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021 Mar 2;19(3):329-359.

3. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer;Van Cutsem;Ann Oncol,2016

4. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N Engl J Med,2004

5. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study;Saltz;J Clin Oncol,2008

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Opportunities and Challenges of Small Molecule Inhibitors in Glioblastoma Treatment: Lessons Learned from Clinical Trials;Cancers;2024-08-29

2. Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Versus Cetuximab as Maintenance Therapy in First-Line Therapy for RAS and BRAF Wild-Type Metastatic Colorectal Cancer: Phase III ERMES Study;Journal of Clinical Oncology;2024-04-10

3. Maintenance strategies after anti-EGFR-based induction in metastatic colorectal cancer: A systematic review and bayesian network meta-analysis;Critical Reviews in Oncology/Hematology;2023-11

4. Optimizing the first-line treatment for metastatic colorectal cancer;Frontiers in Oncology;2023-10-16

5. An Update on the Pivotal Roles of Probiotics, Their Components, and Metabolites in Preventing Colon Cancer;Foods;2023-10-09